hemodialysis
hemodialysis
1. Another 12 normotensive hemodialysis patients were as the control group.
12例血压正常的血液透析患者，作为对照组。
2. Hemodialysis is able to decease IL 13 production in patients with CRF.
:IL - 13可能参与 CRF患者免疫炎症调节进程 ,hd可使其水平降低
3. Hemodialysis can rectify uraemia patients bleeding tendency through improving the platelet activation function,hemodialysis can help to resume the immunity in uraemia patients.
:血液透析通过改善血小板活化功能来纠正尿毒症性出血倾向 ,血透有助于机体的免疫力的恢复。
4. O. system provide pure water for hemodialysis and peritoneal dialysis, as well as the ultrapure water necessary for pharmaceutical manufacturing.
O.系统能提供血渗析与分解用的纯水，亦能提供于药物制造过程中所需的超纯水。
5. In addition,progressive increase in PC antigen,FPS,DD levels and PC activity were observed in patients with uremic bleeding after hemodialysis treatment( P <0 05 or P <0 01).
TM血透后明显降低 (P<0 .0 0 1) ; 有出血并发症者血浆 PC:Ag、FPS、DD含量及 APC明显升高 (P<0 .0 5或 P<0 .0 1)。
6. CASE REPORT The method of hemodialysis was reasonably made, and an opportune moment, indication and contraindication were selected.
[病例报告 ]制定合理的血液透析方案 ,选择适当的时机、适应症和禁忌症 .
7. There are several ways to treat ARF in burn patients, including peritoneal dialysis (PD), intermittent hemodialysis, and continuous renal replacement therapy (CRRT).
一般而言，连续性血液透析通常使用于血压不稳定或无法接受间歇性血液透析治疗的病患。
8. Like the CHOIR and CREATE studies, earlier randomized controlled trials in patients on hemodialysis and patients with adanced CKD6 found no benefit of high hemoglobin targets.
与这两个研究相仿，早期在血透患者和进展性CKD6期患者所作的随机对照临床试验也未发现高血红蛋白的益处。
9. Restrict control of sodium intake, hemodialysis and resection of necrotic tissue are effective measures for the management of burn hypernatremia.
严格的限制钠摄入、血液透析和坏死组织切除是有效的治疗方法。
10. In order to obtain a real-time and correct test for body water equilibrium in hemodialysis patients,an instrument based on bioimpedance measurement has been developed.
为了实时地正确评价血液透析患者的体液平衡状态，作者设计并研制了生物电阻抗法为基础的体液状态测试仪。
11. Discussed the relation between the choices of vascular access for acute hemodialysis and their complications as well as nursing interventions in 72 cases.
为探讨急性血液透析（血透）时建立血管通路与适应证和并发症发生的关系。
12. Surveillance and control of the quality of hemodialysis water has become much necessary in order to avoid contacting noxious substances.
为避免接触已知的或可能的有害物质，监测和控制透析用水的水质非常必要。
13. Introduce the phenomena,analysis,reason and processing of the trouble FL08 emerged in Hemodialysis System,Baxter SPS1550.
介绍百特SPS1550型血液透析机FL08故障现象、分析、原因与处理。
14. Data were analyzed using the content analysis method.Findings delineated five quality of life themes and ten sub-themes for hemodialysis patients.
以内容分析法进行资料分析，最后归纳出病患的生活品质主观经验由五个主要主题与十个次主题所构成。
15. Conclusion The thrombolytic treatment using urokinase is an effective method in thrombosed hemodialysis autologous arteriovenous fistulae.
但对于女性患者、血栓较为陈旧及存在血栓性静脉炎等情况疗效可能不理想。
16. Your doctor will help you decide whether hemodialysis or peritoneal dialysis is right for you. Diabetes control remains important no matter which type of dialysis is chosen.
你的医生会帮助你决定是进行血液透析还是腹膜透析，哪个更适合你。不管何种透析方式，糖尿病控制都是非常重要的。
17. Blood access made by the double-lumen catheters showed significant effect in hemodialysis.
使用双腔导管作为血管通路进行血液透析具有显著优越性
18. We conducted a survey of 168 hemodialysis patients in a single territorial hospital for uremic pruritus experience and possible associated factors.
共有168位病患被收案，收集其就医资料并以标准化问卷评估尿毒性搔痒症的严重性，再加以统计分析。
19. Analyzes the cause of malfunctions for Fresenius 400 hemodialysis machine.And describes the measures of troubleshooting.
分析了费森尤斯4008机型血透机软故障,并介绍了解决该故障的方法。
20. Okonek S,Hofmann A,Henningsen B:Efficacy of gut lavage,hemodialysis,and hemoperfusion in the therapy of paraquat or diquat intoxication[J].ArchToxicol 1976,15,36(1):4351.
刘丽娜，赵金垣，陈莉，等.茶多酚对急性百草枯中毒大鼠治疗作用的实验研究[J].中华劳动与职业病杂志，2000,18(3):158.
21. Cuffed dual-lumen central venous catheters (DLCVC) have been used increasingly in hemodialysis treatment.
双腔中央静脉留置导管在血液透析方面的使用愈来愈广泛，也愈来愈重要。
22. Oral folic acid with HD treatment cannot totally normalize tHcy in hemodialysis patients.
口服叶酸结合hd治疗不能完全纠正hd患者HHcy。
23. It concludes that early hemodialysis is the important measure of saving the severe EHF.
可见尽早进行血液透析是抢救重型流行性出血热的关键措施。
24. Jean G,Chazot C,Vanel T, et al . Central vanous catheters for hemodialysis: looking for optimal blood flow[J].Nephrol Dial Transplant, 1997;12(8):1689.
叶朝阳,袁志忠.长期留置导管在维持血液透析患者的应用与随访[J].中华肾脏病杂志,2001;9(6):342.
25. We describe a hemodialysis patient presenting with acute progressive hypercalcemia from delayed bone metastases of RCC three years after bilateral nephroureterectomy.
在本文中，我们报导了一名长期接受血液透析的病人因肾细胞癌接受双侧肾及输尿管切除术三年后，因异时骨骼转移而出现急性的高血钙症。
26. In some cases, hemodialysis is necessary for fluoride removal and for correction of hyperkalemia.
在某些情况下，为了除去氟化物和纠正血钾过多，必须进行血液透析。
27. Applied during hemodialysis, the effect rate were 8.3%, 71.4%, 68.2% respectively in midodrine hydrochloride tablet group compound amino acid group, 50% glucose group.
在透析中出现症状后应用，有效率分别为：盐酸米多君8.3%，复方氨基酸71.4%，50%葡萄糖68.2%。
28. Nursing of using dual lumen catheter with dacron cuffed through subclavical vein to set up permanent hemodialysis access.
埋藏式双腔静脉留置插管常见并发症的预防和护理
29. The experimental results provided a theoretical basis for evaluating the sufficiency of hemodialysis reasonably.
实验结果为合理地评价透析的充分性提供了理论根据。
30. The tunneled cuffed catheter (TCC) is a vital vascular access for the patients who are undergoing hemodialysis or can't establish arterio-venous fi stula.
对于无法建立动静脉内瘘的维持性血液透析患者,长期留置的中心静脉导管(TCC)是其重要的血管通路,而导管血栓形成已经成为严重影响TCC使用寿命的主要并发症之一。
31. It should be caucious to choose hemodialysis for the patients with serious cardiopathy.
对有严重心脏病的患者选择血液透析应谨慎。
32. Good and efficient blood access is necessary for long-term hemodialysis and titanium ring is suitable for A-V fistulation.
建立良好的血管通路是保障老年患者长期透析的必备条件，应用钛环作动静脉内瘘对老年患者较适宜。
33. Research the start-quo of psychological intervention for patients with hemodialysis.
心理干预对维持性血液透析患者心理状态变化的研究。
34. Conclusions The incidence of cardiac dilatation in the patients with ESRD undergoing maintenance hemodialysis is high.
心脏扩大与年龄、血液透析病程、每周血液透析时间和低蛋白血症无相关关系。
35. To summary 20 cases of hemodialysis with artificial vascular fistula.The key point of nursing is to master the methods of puncture and hemostasis,prevent the complications.
总结了20例老年血液透析患者建立人造血管内瘘的应用和护理。护理要点在于掌握其穿刺和止血方法,对病人做好卫生宣教,预防并发症的发生。
36. Infected pseudoaneurysm from hemodialysis vascular access was highly suspected.
我们便高度怀疑，这是源自血管通路之感染性伪动脉瘤。
37. We suggest that improing uremia by nocturnal hemodialysis in the absence of exogenous supplementation is associated with increased 25 and 1,25-hydroxy-itamin D leels.
我们认为，通过外源性补充的缺乏的夜间血液透析而症状改善的尿毒症,和增加的25-和1,25二羟维生素D的水平相关。
38. Abstract Objective : To study the changes of neuropeptide Y(NPY) and neurotensin (NT) in platelet extract and plasma in hemodialysis (HD).
摘 要 目的： 探讨血液透析(HD)过程血小板中神经肽Y(NPY)与神经降压素(NT)的含量变化及意义。
39. Abstract Objective To investigate the quality of life(QoL) of maintenance hemodialysis(MHD) patients in Beijing suburb.
摘要 目的 了解北京市郊区维持性血液透析(MHD)患者的生活质量。
40. Objective To observe the prevalence and clinical relevance of hepatitis B,C infection in maintenance hemodialysis (MHD) patients.
摘要 目的 了解维持性血液透析患者病毒性肝炎的感染率及其有关因素。
41. Abstract Objective To analyse the survival rate and cause of death of the patients of end stage renal disease (ESRD)on maintenance hemodialysis(MHD).
摘要 目的 回顾性分析169例终末期肾病（ESRD）维持性血液透析（MHD）患者的生存率及死亡原因。
42. Abstract Objective To investigate the effect of minoxidil for hemodialysis patients with refractory hypertension.
摘要 目的 探讨米诺地尔在维持性血液透析患者中的降压作用。
43. Abstract Objective To investigate the clinical character of snuffbox arteriovenous fistula(SAV)in hemodialysis patients.
摘要 目的 探讨老年尿毒症患者建立鼻烟窝自体动静脉内瘘的临床特点。
44. Abstract Objective To investigate the influence of calcium concentration in dialysate on dialysis-related refractory hypertension in maintenance hemodialysis (HD) patients.
摘要 目的 探讨透析液钙浓度变化对血液透析相关性难治性高血压的影响。
45. Abstract Objective To study the effect of individualized dialysate temperature on hemodialysis complications.
摘要 目的 研究个体化透析液温度处方对维持血液透析患者透析中并发症的影响。
46. Objective To observe the eyeground pathological changes in maintenance hemodialysis patients, and to analyse the possible related factors of its high incidence.
摘要 目的 观察维持性血液透析患者眼底病变状况，分析其发生率高的可能相关因素。
47. Abstract Objective: To investigate the effects of dialysis with balancing amino acid dialysate in chronic hemodialysis patients.
摘要 目的：设计平衡型氨基酸透析液，应用于维持性血透患者常规血透治疗，观察临床应用效果。
48. This study describes the issues related to pruritus and self-management in hemodialysis (HD) patients.
摘要本研究系描述血液透析患者皮肤搔痒之相关问题，以做为皮肤痒之护理实证参考。
49. Objective To investigate hepatitis C virus (HCV) infection in hemodialysis patients and to improve the control of noaocomial infection of HCV.
摘要目的瞭解血液透析（血透）患者丙型肝炎病毒(HCV)感染情况，进一步做好上述人群医院感染控制工作。
50. Objective To investigate the distribution, risk factors and preventive measures of infection in patients with maintenance hemodialysis.
摘要目的探讨维持性血液透析患者感染的分布、危险因素及预防措施。
51. Objective To investigate the effect and cordis complication of hemodialysis in the elderly.
摘要目的研究256例老年人血液透析疗效和心血管并发症。
52. Objective To study the cardiovascular stability of treatment with hyperkalemia Hemodialysis.
摘要目的观察适当提高透析液钾离子浓度在临床中的效果。
53. Objective: To appraise the effect of the improved-centesis using for A-V fistula of the cases needed hemodialysis.
摘要目的：探讨改良穿刺法对血透患者动静脉瘘使用效果观察及护理。
54. Objective: To investigate the clinical features and control method of nosocomial infection (NI) in patients on maintenance hemodialysis in our hospital.
摘要目的：探讨血液透析患者的医院感染(NI)特点及其预防控制措施。
55. Heparin, a commonly used anticoagulant agent, is frequently used in patients undergoing hemodialysis.
摘要肝素（一种常使用的抗凝血剂）经常用在须要洗肾的病人身上。
56. As a substitute for the function of kidney, hemodialysis therapy has been widely applied to clinical therapy.
摘要血液透析作为肾功能的替代方法，已广泛地应用于临床治疗。
57. Hemodialysis is one of the best methods to treat acute or chronic renal failure, drug poisoning and food poisoning.
摘要血液透析技术是治疗急慢性肾功能衰竭和药物、毒物中毒最有效的措施之一。
58. Abstract: Hemodialysis is a main substitutive therapy for nephrosis patients at terminal stage.
摘要：血液透析是终末期肾病患者的主要替代疗法。
59. Use of ultrapure dialysate in reduction of chronic inflammation during Hemodialysis .
文章的名字Arizono K,Nomura K,Motoyama T,et al.
60. Methods: TTV DNA was detected in serum and PBMC of 66 hemodialysis patients by polymerase chain reaction (PCR). HBsAg and Anti HCV in sera was detected by EIA.
方法 :采用聚合酶链反应 (PCR)对 6 6例血液透析患者血清及PBMC进行TTV DNA检测 ,同时采用酶免疫分析 (EIA)检测血清中HBsAg和抗 HCV。
61. Methods To compare the clinical effect of SAV between the elderly and young hemodialysis patients.
方法 比较老年和青年尿毒症患者建立鼻烟窝自体动静脉内瘘应用于血液透析的临床疗效。
62. Methods In 80 hemodialysis patients, there are 9 snuff-box arteriovenous fistulas and 71 brachiocephalic fistulas.
方法 选取我院透析患者80例，鼻烟窝内瘘9例，左、右前臂内瘘71例，其中在同侧行二次手术为16例；
63. Methods Forty hemodialysis and 36 peritoneal dialysis pati ents were measured by HAMD, compared the HAMD marks between two groups.
方法 采用汉密尔顿抑郁量表(HAMD)对40例血液 透析患者和36例腹膜透析患者评估，比较评分的差异，同时比较程度的差异。
64. Method: A total of 166 cases patients were conducted hemodialysis via direct arterio puncture and venous puncture for 4300 times.
方法:对166例患者直接动、静脉穿刺血液透析4300次,术后血肿进行分析,并实施针对性护理。
65. Methods: Access recirculation was assayed by both urea test (UT) and GIT in 82 hemodialysis patients, and 17 patients were also examined by Doppler ultrosonics method.
方法:对82例维持性血透患者的血管通路采用尿素法(UT)和GIT两种方法进行再循环率测定,进行自身对照。
66. Methods: 83 cases of perpetual AVF were made on stable hemodialysis patients ,a retrospective analysis was performed to study the causes of AVF obturation .
方法:对83例建立永久性AVF并作维持性血液透析患者进行回顾性对照分析,以了解AVF闭塞的情况及其原因。
67. Methods:Low molecular heparin sodium anticoagulation was used to carry out hemodialysis.
方法:应用吉派林(低分子肝素钠)作为抗凝剂进行血液透析。
68. Methods: To observe the average hospitalization day and the time that kidney function began recovering in hemodialysis group and no-hemodialysis group.
方法:观察血液透析组与非血液透析组的平均住院日、肾功能恢复的时间、病情转归。
69. Methods:We used the prescription of glucose-free bicarbonate dialysate and applied it to hemodialysis for 185 chronic renal failure patients.
方法:采用无糖型碳酸氢盐透析液组方,用于185例慢性肾功能衰竭患者进行血液透析。
70. Methods A group use bicarbonate hemodialysis and common medical treatment, B group use common hemodialysis at ARF and CRF.
方法A组采用碳酸氢盐血液透析及常规内科治疗,B组仅ARF或CRF有血液透析指征时进行普通血液透析治疗,并观察效果。
71. Methods M mode and two dimensional UCG were analyzed in 38 hemodialysis cases with uremia.
方法分析 38例尿毒症血透患者的 M型及二维 UCG和临床资料。
72. Methods M-mode and two-dimensional UCG were analyzed in 38 hemodialysis cases with uremia.
方法分析38例尿毒症血透患者的M型及二维UCG和临床资料。
73. Methods Central double-lumen catheters in the jugular or femoral vein for hemodialysis are used in 25 patients with uremia.
方法对25例尿毒症患者使用双腔导管建立颈内静脉或股静脉血管通路。
74. Methods The histories of 44 aged patients with AHF in maintenance hemodialysis were analyzed in this paper.
方法对44例血液透析中并发的急性左心衰竭进行回顾分析。
75. Methods 52 patients were divided into three groups according to serum albumin levels(>35g/L,25-35g/L,<25g/L),then incidence rate of hypotension during hemodialysis was observed.
方法按血清白蛋白水平分为三组:血清白蛋白>35g/L组、25-35g/L组和<25g/L组,观察三组在血透期间低血压的发生率。
76. Methods Plasma free carnitine was detected with radiochemical-enzymatic assay which was evaluated statistically in 30 health blood donors and 30 hemodialysis patients.
方法用放射性同位素酶化学法测定血浆游离肉碱，然后检测健康献血员及血液透析(血透)患者各30例，并与透析时间及透析并发症发生率作相关分析。
77. Methods 26 old patients with uremia were treated by maintenance Hemodialysis,and the variety of clinical manifestations and biochemical indexes were observed before and after MHD.
方法维持性血液透析治疗老年尿毒症患者26例,观察其血透前后各种临床和生化指标的变化。
78. Methods Self-evaluation Depression Scale(SDS)was adopted to conduct psychol ogical evaluation for50patients in Centre for Hemodialysis.
方法采用抑郁自评量表对50例透析患者进行心理测评。
79. Methods By questionaire method, 125 cases of hemodialysis patients were investigated.
方法采用问卷方式调查了125名血液透析病人。
80. Methods:Pre-hemodialysis and post-hemodialysis plasma ANP and cardiothoracic ratio(CTR) were evaluated in 26 chronic hemodialysis patients.
方法：26例慢性血液透析病人在透析前后分别测定血浆ANP、CTR及体重。
